Drug recall D-1446-2020
Product
Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12
Reason for recall
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Lots and codes
Lots: Tray lot: 13405DK Vial lot: 13-405 DK Exp. 1JUL2021, Tray lot: 17096DK Vial lot: 17-096-DK Exp. 1NOV2021
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 19,144 vials
- Distribution
- United States including Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 20, 2020
- Terminated
- December 8, 2022
Related products
- Fentanyl Citrate – drug information
- NDC 0409-9093 Fentanyl Citrate · Fentanyl Citrate 50 ug/mL · Hospira, Inc.
- NDC 0409-9094 Fentanyl Citrate · Fentanyl Citrate 50 ug/mL · Hospira, Inc.